BRIGhTMIND study: long-term efficacy of rTMS for treatment-resistant depression

IMG 3184

BRIGhTMIND is a study which highlights the long-term efficacy of repetitive transcranial magnetic stimulation (rTMS) for patients with treatment-resistant depression. When compared with connectivity-guided intermittent theta burst stimulation (cgiTBS) in a randomized control trial, both treatments were equally effective, with persistent decreases in depressive symptoms seen over 26 weeks.

Click here to read the full article